Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 57

Sort by

Sort Order Select

Journal Articles

Natural History of Skeletal Related Events in Patients with Multiple Myeloma Who Received First- and Second- Line Therapy with Novel Agents: Results from a Single Center Analysis in 620 Patients

Evangelos Terpos, MD PhD, Nikolaos Kanellias, MD, Eftathios Kastritis, Maria Gavriatopoulou, MD, Vassilis Koutoulidis, MD, Ioannis Ntanasis-Stathopoulos, MD, Aristea-Maria Papanota, MD, Despina Fotiou, MD, Magdalini Migkou, MD, Evangelos Eleutherakis-Papaiakovou, MD, Panagiotis Malandrakis, MD, Tina Bagratuni, PhD, Maria Roussou, MD, Lia A. Moulopoulos, MD, Meletios A. Dimopoulos, MD

Blood (2019) 134 (Supplement_1): 4326.

https://doi.org/10.1182/blood-2019-123606

Published: 2019

Journal Articles

Tumor-Specific Cell-Free DNA (cfDNA) in the Cerebrospinal Fluid (CSF) Detects Cytologically Occult Central Nervous System (CNS) Involvement in Aggressive Lymphomas

Adam J Olszewski, MD, Anna D Chorzalska, PhD, Diana O Treaba, MD, John L Reagan, MD, Pamela C Egan, MD, Habibe Kurt, MD, James Butera, MD, William Rafelson, MDMBA, Alexander C Mohler, MD MS, Thomas A Ollila, MD, Rabin Niroula, MBBS, Jordan Robison, CRA, Chelsea D Mullins, BS, Patrycja M Dubielecka, PhD

Blood (2019) 134 (Supplement_1): 2800.

https://doi.org/10.1182/blood-2019-125475

Published: 2019

Journal Articles

Real Life Use of Imaging in the Management of Newly Diagnosed Patients with Myeloma- Practical Perspectives from a UK Hospital

Ke Xu, MD, Lucy Fowkes, Fenella Willis, Yasmin Reyal

Blood (2019) 134 (Supplement_1): 5513.

https://doi.org/10.1182/blood-2019-121504

Published: 2019

Journal Articles

Prognosis after Upfront Radiation Therapy in Plasma Cell Myeloma: Analysis of the National Cancer Data Base

Xavier Orcutt, BA, Peter Barth, MD, Adam J Olszewski, MD

Blood (2018) 132 (Supplement 1): 3230.

https://doi.org/10.1182/blood-2018-99-110108

Published: 2018

Journal Articles

Clinical Responses and Pharmacokinetics of MCARH171, a Human-Derived Bcma Targeted CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma: Final Results of a Phase I Clinical Trial

Blood (2018) 132 (Supplement 1): 959.

https://doi.org/10.1182/blood-2018-99-119717

Published: 2018

Journal Articles

Use of Bone-Modifying Agents and Outcomes of Myeloma Therapy: A Population-Based Study

Adam J Olszewski, MD, Peter Barth, MD, John L. Reagan, MD

Blood (2018) 132 (Supplement 1): 709.

https://doi.org/10.1182/blood-2018-99-110739

Published: 2018

Journal Articles

Multiple Myeloma Patients and Risk of Skeletal Related Events - Real-World Evidence in US Oncology Clinics

Sumita Bhatta, MD, Lori Cyprien, Rafael Fonseca, MD, Rohini K Hernandez, PhD, Christopher Kim, PhD

Blood (2017) 130 (Supplement 1): 2171.

https://doi.org/10.1182/blood.V130.Suppl_1.2171.2171

Published: 2017

Journal Articles

C-Reactive Protein Promotes Bone Destruction in Human Myeloma By Stimulating Myeloma Cell Production of Osteolytic Cytokines Via the CD32/FcγRII-p38MAPK-Twist Axis

Jing Yang, PhD, Zhiqiang Liu, PhD, Huan Liu, PhD, Jin He, Jianling Yang, PhD, Pei Lin, MDDM,MDC, Qiang WANG, PhD, Juan Du, PhD MD, Wencai Ma, Richard E Davis, BSPharm, MS, Robert Z. Orlowski, MD PhD, Jian Hou, MD, Qing Yi, MD PhD

Blood (2017) 130 (Supplement 1): 3043.

https://doi.org/10.1182/blood.V130.Suppl_1.3043.3043

Published: 2017

Journal Articles

Extra Medullary Hematopoiesis in Patients with Polycythemia Vera Rare and Unusual Presentations

Mohamed A. Yassin, MBBS, MSc, CABM, FACP, Shehab Mohamed, Abdulqadir Nashwan

Blood (2016) 128 (22): 5491.

https://doi.org/10.1182/blood.V128.22.5491.5491

Published: 2016

Journal Articles

Report of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in Four Patients with Hematological Malignancies Treated at King Fahad Medical City, Riyadh, Saudi Arabia

Ibraheem H Motabi, MRCP MD, Syed Ziauddin A. Zaidi, MBBS, FRCP, FCPS, FRCPath, FACP, Mamoun Hassan Ibrahim, MBBS, MRCPI, SBAH, Imran K Tailor, MBBS, MD FRCP, FRCPath, Nawal Faiez Alshehry, MD SBIM, SBAH, Mubarak S. AlGhamdi, MD, Shahid Iqbal, MBBS, FCPS, MRCP, Samer Mudaibigh, MD SBIM, SBAH, Fouad H Alnajjar, PharmD, MSc, BCOP

Blood (2016) 128 (22): 4903.

https://doi.org/10.1182/blood.V128.22.4903.4903

Published: 2016

Journal Articles

Utilization Patterns of Bone-Targeting Agents Among Patients with Multiple Myeloma: Analysis of Real-World Data

Yi Qian, PhD, Debajyoti Bhowmik, B.Pharm, PhD, Nandita Kachru, MS, Rohini K. Hernandez, PhD, Paul Cheng, MD PhD, Alexander Liede, BSc, MSc, PhD

Blood (2015) 126 (23): 4501.

https://doi.org/10.1182/blood.V126.23.4501.4501

Published: 2015

Journal Articles

Urinary Protein Levels in Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM) Predict Severe Disease Related Complications at Myeloma Progression

Angelo Belotti, MD, Michele Malagola, Claudia Crippa, MD, Ilaria Prezioso, Francesca Schieppati, Rossella Ribolla, Vincenza Orlando, Domenico Russo, Giuseppe Rossi, MD

Blood (2015) 126 (23): 2965.

https://doi.org/10.1182/blood.V126.23.2965.2965

Published: 2015

Journal Articles

Drug Resistant Myeloma Cells Cause More Severe Bone Destruction in Myeloma

Mu Hao, MD PhD, Zhimin Gu, PhD, Reinaldo Franqui Machin, Hongwei Xu, Gregory S. Thomas, PhD, Lugui Qiu, MD PhD, Guido J Tricot, MD PhD, Fenghuang Zhan, MD PhD

Blood (2015) 126 (23): 839.

https://doi.org/10.1182/blood.V126.23.839.839

Published: 2015

Journal Articles

Statin Use and Its Effects on Skeletal Related Events in Patients with Multiple Myeloma

Fernando M Vargas Madueno, MD, Amin Benyounes, MD, Gentry King, MD, Kuan-Hsiang Gary Huang, MDPhD, Gabor Varadi, MD

Blood (2014) 124 (21): 5774.

https://doi.org/10.1182/blood.V124.21.5774.5774

Published: 2014

Journal Articles

Front-Line Radiotherapy Is Associated with Shortened Survival in Newly Diagnosed Multiple Myeloma Patients

Mark A. Fiala, BS, CCRP, Jesse Keller, MD, Keith E. Stockerl-Goldstein, MD, Michael H. Tomasson, MD, Ravi Vij, MBBS, MD, Tanya M Wildes, MD MSCI

Blood (2014) 124 (21): 5696.

https://doi.org/10.1182/blood.V124.21.5696.5696

Published: 2014

Journal Articles

Impact of Radiation Therapy on Stem Cell Harvest in Multiple Myeloma

Sandra Sauer, Andreas Marco Fischer, Andrea Fraenzle, Christina Kunz, PhD, Maximilian Merz, MD, Patrick Wuchter, Martina Schmaus, Anthony D. Ho, Prof., MD FRCPC, Hartmut Goldschmidt, MD, Jens Hillengass, MD

Blood (2014) 124 (21): 5822.

https://doi.org/10.1182/blood.V124.21.5822.5822

Published: 2014

Journal Articles

Vitamin D Levels Are Frequently below Normal in Multiple Myeloma Patients and Are Infrequently Assessed By Their Treating Physicians

Noah Ravenborg, Kyle Udd, Ariana Berenson, Fritz Costa, James R. Berenson, MD

Blood (2014) 124 (21): 5769.

https://doi.org/10.1182/blood.V124.21.5769.5769

Published: 2014

Journal Articles

Cerebrospinal Fluid (CSF) Involvement By Plasma Cell Dyscrasias – Single Center Experience

Taiga Nishihori, MD, Jun Zhou, MD, Kenneth H. Shain, MD PhD, Rachid Baz, MD, Melissa Alsina, MD, Daniel Sullivan, MD MS, Ryan Hillgruber, Elizabeth M. Sagatys, MD, Lynn C. Moscinski, MD, Ling Zhang, MD

Blood (2014) 124 (21): 5686.

https://doi.org/10.1182/blood.V124.21.5686.5686

Published: 2014

Journal Articles

Management of Verterbral Compression Fractures (VCFs) in Multiple Myeloma (MM) Patients with Balloon Kyphoplasty

Charalampia Kyriakou, MD PhD Consultant Haematologist, Anand Patel, Shivan Jassim, Adam Benton, Susanne Selvadurai, Syed Aftab, Amr Fahmy, Mathew David Sewell, Sean Molloy

Blood (2014) 124 (21): 3482.

https://doi.org/10.1182/blood.V124.21.3482.3482

Published: 2014

Journal Articles

Neuropathy and Efficacy Of Weekly Subcutaneous Bortezomib In Myeloma and AL Amyloidosis

Surbhi Sidana, MD, Beth Faiman, PhDc, CNP, Paul Elson, ScD, Mitchell R Smith, MD, PhD, Robert M Dean, MD, Jason Valent, M.D., Christy Samaras, DO, Hien K. Duong, MD, Debbie Hastings, Kellie Bruening, Frederic J. Reu, MD

Blood (2013) 122 (21): 1975.

https://doi.org/10.1182/blood.V122.21.1975.1975

Published: 2013

NARROW

Natural History of Skeletal Related Events in Patients with Multiple Myeloma Who Received First- and Second- Line Therapy with Novel Agents: Results from a Single Center Analysis in 620 Patients

Tumor-Specific Cell-Free DNA (cfDNA) in the Cerebrospinal Fluid (CSF) Detects Cytologically Occult Central Nervous System (CNS) Involvement in Aggressive Lymphomas

Real Life Use of Imaging in the Management of Newly Diagnosed Patients with Myeloma- Practical Perspectives from a UK Hospital

Prognosis after Upfront Radiation Therapy in Plasma Cell Myeloma: Analysis of the National Cancer Data Base

Clinical Responses and Pharmacokinetics of MCARH171, a Human-Derived Bcma Targeted CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma: Final Results of a Phase I Clinical Trial

Use of Bone-Modifying Agents and Outcomes of Myeloma Therapy: A Population-Based Study

Multiple Myeloma Patients and Risk of Skeletal Related Events - Real-World Evidence in US Oncology Clinics

C-Reactive Protein Promotes Bone Destruction in Human Myeloma By Stimulating Myeloma Cell Production of Osteolytic Cytokines Via the CD32/FcγRII-p38MAPK-Twist Axis

Extra Medullary Hematopoiesis in Patients with Polycythemia Vera Rare and Unusual Presentations

Report of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in Four Patients with Hematological Malignancies Treated at King Fahad Medical City, Riyadh, Saudi Arabia

Utilization Patterns of Bone-Targeting Agents Among Patients with Multiple Myeloma: Analysis of Real-World Data

Urinary Protein Levels in Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM) Predict Severe Disease Related Complications at Myeloma Progression

Drug Resistant Myeloma Cells Cause More Severe Bone Destruction in Myeloma

Statin Use and Its Effects on Skeletal Related Events in Patients with Multiple Myeloma

Front-Line Radiotherapy Is Associated with Shortened Survival in Newly Diagnosed Multiple Myeloma Patients

Impact of Radiation Therapy on Stem Cell Harvest in Multiple Myeloma

Vitamin D Levels Are Frequently below Normal in Multiple Myeloma Patients and Are Infrequently Assessed By Their Treating Physicians

Cerebrospinal Fluid (CSF) Involvement By Plasma Cell Dyscrasias – Single Center Experience

Management of Verterbral Compression Fractures (VCFs) in Multiple Myeloma (MM) Patients with Balloon Kyphoplasty

Neuropathy and Efficacy Of Weekly Subcutaneous Bortezomib In Myeloma and AL Amyloidosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only